Curanex Pharmaceuticals Inc Common Stock (CURX)

Curanex Pharmaceuticals Inc Common Stock (CURX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.5M; returns 1 day -10.8%, 1 week +0.4%, 1 year -64.1%.

Curanex Pharmaceuticals Inc. is a developmental-stage pharmaceutical company focused on the discovery and development of botanical drugs for inflammatory diseases. As a pre-revenue company, its business model is entirely centered on advancing its lead product candidate, Phyto-N, through the clinical trial process to eventual commercialization.

Groups CURX belongs to

• Biotechnology
• Recent Reverse Splits
• Pharmaceuticals
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Chronic Inflammatory Diseases
• Gastroenterology
• Drug Discovery

CURX financial model: income statement, cash flow and balance sheet